DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 124 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $425,723 | -8.9% | 30,236 | 0.0% | 0.01% | -10.0% |
Q1 2023 | $467,146 | -57.5% | 30,236 | -54.9% | 0.01% | -60.0% |
Q4 2022 | $1,098,425 | -44.4% | 67,018 | -37.2% | 0.02% | -49.0% |
Q3 2022 | $1,974,000 | +141.3% | 106,689 | +27.5% | 0.05% | +157.9% |
Q4 2021 | $818,000 | -73.8% | 83,663 | -8.9% | 0.02% | -77.9% |
Q3 2021 | $3,121,000 | +1114.4% | 91,843 | +1208.9% | 0.09% | +975.0% |
Q2 2021 | $257,000 | -59.8% | 7,017 | -77.0% | 0.01% | -91.4% |
Q4 2018 | $639,000 | +31.5% | 30,454 | +142.6% | 0.09% | +93.8% |
Q3 2018 | $486,000 | – | 12,552 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |